Valencia Nutrition Ltd Board Meeting

47.07
(5.00%)
Jul 23, 2024|03:40:00 PM

Valencia Nutrit. CORPORATE ACTIONS

24/07/2023calendar-icon
23/07/2024calendar-icon
PurposeBoard Meetings DateAnnouncement Date
Board Meeting30 May 202420 May 2024
Valencia Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2024 inter alia to consider and approve and take on record the audited financial results for the year ended as on March 31 2024 along with the Auditors Report thereon. 2. Any other matter with the permission of the Chair. The Board of Directors in their meeting held today i.e. Thursday, May 30, 2024 have inter alia, approved the standalone financial statement for the half-year ended and year ended March 31, 2024 (As Per BSE Announcement Dated on 19.07.2024)
Board Meeting19 Mar 202419 Mar 2024
With reference to the captioned Rights Issue, we would like to inform you that as per the resolution passed by the Board of Directors of the Company dated 19th March, 2024 the date of closure of the captioned Right Issue, which had opened on Friday, 15th March, 2024 and scheduled to close on Friday, 22nd March, 2024 has now been extended by the Company from Friday, 22nd March, 2024 to Friday, 12th April, 2024 in order to provide an opportunity to shareholders to exercise their rights in the Rights Issue. Further, the last date of market renunciation of Right Entitlement shall be extended to April 05, 2024.
Board Meeting6 Mar 20246 Mar 2024
This is further to our intimation dated December 07, 2023, the Board of Directors of our Company, at their meeting held today, i.e. Wednesday, March 06, 2024 (Commencement time 02:30 PM and Conclusion time 04:20 PM) have considered and approved inter alia the terms of the Rights Issue. Intimation for Record Date and ISIN for the Rights Entitlements to be credited for the purpose of Rights Issue.
Board Meeting9 Feb 20249 Feb 2024
Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with Part A of Schedule III, we wish to inform your good office that the meeting of the Board of Directors of Valencia Nutrition Limited held today i.e. Friday, February 09, 2024, at 03.30 p.m. and concluded at 04.45 p.m. has inter alia, approved the following item: 1. The approval of the board be and is hereby accorded to avail short-term unsecured Bridge Loan for proposed rights issue up to an amount of Rs. Rs. 3,00,00,000 (Rupees Three Crores only) from the Non-banking Financial Company- Abans Finance Private Limited for financing the Companys funding requirements on such terms and conditions as may be mutually agreed upon between the Company & lender. Further, the said short-term unsecured Bridge loan will be repaid out of the net proceeds of the rights issue.
Board Meeting30 Dec 202327 Dec 2023
Valencia Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/12/2023 inter alia to consider and approve As attached. In furtherance to our intimation dated December 27, 2023 and in pursuance of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, including subsequent amendments thereto [SEBI (LODR) Regulations], the Board of Directors in their meeting held on December 30, 2023 at the registered office of the Company situated at 601A, Neelkanth Business Park, Nathani Road, Vidyavihar (West), Mumbai, Maharashtra, 400086 commenced at 11:00 A.M. and concluded at 12:00 Noon has discussed and approved the Draft Letter of Offer for the proposed Rights Issue of the Company for an aggregate amount up to Rs. 22,00,00,000 (Rupees Twenty Two Crores Only) to be filed with BSE Limited (the Stock Exchange) for their in-principle approval for listing of the Rights Equity Shares on their exchanges. (As Per BSE Announcement dated on 30.12.2023)
Board Meeting12 Dec 20237 Dec 2023
Inter alia, to consider and approve the following business: 1. Reclassification of Ms. Deepthi Anand from Promoter/Promoter Group to Public Category pursuant to Regulation 31A of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. 2. The Management has proposed to revise the size of the raising of funds earlier decided in the Board Meeting held on November 20, 2022, through issuance and allotment of equity shares on right issue basis from an aggregate amount of up to Rs. 14,00,00,000 (Rupees Fourteen Crores Only) to not more than Rs. 22,00,00,000 (Rupees Twenty-Two Crores Only). 3. Any other matter with the permission of the Chair. In furtherance to our intimation dated December 07, 2023, and in pursuance of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, including subsequent amendments thereto [SEBI (LODR) Regulations], the Board of Directors in their meeting held on December 12, 2023 at the registered office of the Company situated at 601A, Neelkanth Business Park, Nathani Road, Vidyavihar (West), Mumbai, Maharashtra, 400086 commenced at 11:00 AM. and concluded at 12:00 Noon has approved and took on records as attached. (As Per BSE Announcement Dated on 12.12.2023)
Board Meeting20 Nov 202310 Nov 2023
Valencia Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/11/2023 inter alia to consider and approve The proposal for fund raising by the issue of permissible securities including a rights issue preferential issue or through any other permissible mode or a combination thereof subject to such regulatory/ statutory approvals as may be required. The Board of Directors of the Company in their meeting held on Monday, November 20, 2023 have approved the following: 1. Raising of funds through issuance and allotment of equity shares for an aggregate amount of up to Rs. 14,00,00,000 (Rupees Fourteen Cores Only) on right issue basis, on such terms and conditions as may be decided by the Board of Directors of our Company to the eligible equity shareholders of the Company, as on the record date (to be notified subsequently) subject to the receipt of applicable regulatory, statutory approvals, in accordance with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements), Regulations, 2015, and the Companies Act, 2013 and the rules made thereunder, as amended from time to time, (Rights Issue) 2. Appointment of various intermediaries for the aforesaid Rights Issue. Outcome of the Board meeting held on November 20, 2023 (As Per BSE Announcement dated on 20.11.2023)
Board Meeting10 Nov 20232 Nov 2023
Valencia Nutrition Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/11/2023 inter alia to consider and approve the un-audited financial results for the half-year ended on September 30 2023 The Board of Directors of the Company in their meeting held on today i.e. Friday, November 10, 2023 has approved the M/s. SPDS & Associates LLP, Chartered Accountant (FRN:W100383) as an Internal Auditor of the Company for a period of 3 (three) years i.e. upto FY:2025-26. The Board of Directors of the Company in their meeting held on today i.e. Friday, November 10, 2023 which commenced at 2:00 p.m. and concluded at 6:15 p.m. has inter alia, approved the following items: 1. The standalone unaudited financial results for the half year ended as on September 30, 2023, along with the Limited Review Report thereon; 2.Appointment of M/s. SPDS & Associates LLP, Chartered Accountant (FRN: W100383), an Internal Auditor of the Company for a period of 3 (three) years. i.e. upto FY:2025-26. (The brief profile along with other details is attached herewith as Annexure-I.) The Board of Directors in their meeting held today i.e. Friday, November 10, 2023 has approved the standalone unaudited financial result for the half year ended as on September 30, 2023. (As per BSE Announcement Dated on 10/11/2023)
Board Meeting9 Oct 202314 Oct 2023
Intimation of change in the registered office of the Company within the local limit of the city where the registered office of the Company is presently situated
Board Meeting2 Sep 20232 Sep 2023
The Board of Directors of the Company in their meeting held today i.e. September 02, 2023, have inter alia, approved the following items: 1 Approval of the re-designation and appointment of Mr. Manish Turakhia (DIN:02265579), as the Managing Director & KMP of the Company, not liable to retire by rotation for a period of 3 years. 2 Appointment of Mr. Paresh Desai (DIN:07412510), as an Additional Director (Non-Executive Director), liable to retire by rotation. 3 Appointment of Mr. Geet Shah (DIN:08532430), as an Additional Director (Non-Executive, Independent Director), not liable to retire by rotation. 4 Calling of the Companys 10th AGM on Thursday, September 28, 2023, at 11.00 a.m. through VC or OAVM. 5 Considered and approved the Notice of 10th AGM of the Company. 6 The Boards Report and Management Discussion Analysis along with all other necessary Annexures for the F.Y ended March 31, 2023. 7 To appoint the Scrutiniser. It may please be noted that the following changes took place in the management of the Company at the meeting of the Board of Directors held today i.e. September 02. 2023: 1. Appointment of the re-designation and appointment of Mr. Manish Turakhia (DIN:02265579), as the Managing Director & KMP of the Company, not liable to retire by rotation for a period of three years effective from September 02, 2023. 2. Appointment of Mr. Paresh Desai (DIN:07412510), as an Additional Non-Executive Director, liable to retire by rotation w.e.f. September 02, 2023. 3. Appointment of Mr. Geet Shah (DIN:083532430), as an Additional Non-Executive (Independent Director), not liable to retire by rotation w.e.f. September 02, 2023.
Board Meeting29 Aug 202329 Aug 2023
The Board of Directors of the Company in their meeting held on today i.e. Tuesday, August 29, 2023, have inter alia, approved the items pursuant to Regulation 30 read with Schedule III - Part A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Valencia Nutrit.: Related News

No record found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.